Search - tctmd.com

Displaying 441 - 460 of 655

Sort: Relevancy | Date

Session XI: Future Directions and Challenges in the MedTech Field - Featured Technology: Real-World Evidence Generation Technology Using Artificial Intelligence and Deep Learning to Predict Disease Risk and Efficacy of Therapy (HOLMUSK)

Presentation TCT 2019

Featured Technology: Real-World Evidence Generation Technology Using Artificial Intelligence and Deep Learning to Predict Disease Risk and Efficacy of Therapy (HOLMUSK)

Presenter: Joydeep Sarkar

September 26, 2019

News Conference News HFSA 2019

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

L.A. McKeown

September 24, 2019

News Opinion Fellow Talk

What I Am Most Looking Forward to at TCT 2019

Mahesh V. Madhavan, MD

September 18, 2019

News Conference News HFSA 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

L.A. McKeown

September 18, 2019

News Conference News ESC 2019

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

Yael L. Maxwell

September 06, 2019

News Conference News ESC 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Michael O'Riordan

September 05, 2019

News Conference News ESC 2019

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

Shelley Wood

September 01, 2019

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides

Michael O'Riordan

August 21, 2019

News Daily News

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

Todd Neale

August 19, 2019

News Daily News

Substantial Increase in PCI Survival Over 10 Years: Single Center

Yael L. Maxwell

August 16, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Daily News

FDA: Class I Recall for Ellipse ICD Due to Faulty Wires

Shelley Wood

August 05, 2019

News Daily News

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Michael O'Riordan

July 03, 2019

News Daily News

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

Caitlin E. Cox

June 18, 2019

News Daily News

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Caitlin E. Cox

June 13, 2019

News Daily News

Mortality Lower When STEMI Patients Sent to the ICU, but Why?

Todd Neale

June 06, 2019

News Features ESC Heart Failure 2019

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

Shelley Wood

May 30, 2019

News Conference News EuroPCR 2019

New Clarity on Patients at High Risk for Bleeding After PCI

Michael O'Riordan

May 28, 2019

Advertisement

Featured Technology: Real-World Evidence Generation Technology Using Artificial Intelligence and Deep Learning to Predict Disease Risk and Efficacy of Therapy (HOLMUSK)

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

What I Am Most Looking Forward to at TCT 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

Substantial Increase in PCI Survival Over 10 Years: Single Center

FDA Expands TAVR Indication to Low-Risk Patients

FDA: Class I Recall for Ellipse ICD Due to Faulty Wires

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Mortality Lower When STEMI Patients Sent to the ICU, but Why?

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

New Clarity on Patients at High Risk for Bleeding After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content